Scientist - Automation Assay Specialist at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • BS or MS in a relevant field with at least 2 years of industrial R&D experience (neuroscience preferred)
  • Hands-on experience with Tecan Fluent software/hardware, including troubleshooting, minor repairs, device integration, and de novo Fluent Control scripting to meet project needs
  • Experience running manual immunoassays and converting them to automated platforms
  • Proficiency with Microsoft Office (Excel, PowerPoint); familiarity with VBA or other programming languages
  • Strong communication skills and experience teaching or supporting others in a lab environment
  • Experience with worklist-driven scripts, liquid class modification, and labware training
  • Data analysis using GraphPad Prism
  • Experience with ELISA, protein assays, RNA isolation, and cell culture
  • Experience with Tecan hardware including FRIDA, Hydrospeed, carousel, Infinite reader, and phase detection

Responsibilities

  • Develop and implement automated biomarker and workflow strategies
  • Collaborate with cross-functional teams to design and execute preclinical experiments
  • Prepare and process samples from cells, rodents, non-human primates, and humans
  • Plan, optimize, and validate automation scripts for preclinical and clinical analyses
  • Adapt manual methods to automation for high-throughput assays; apply statistical tools for data analysis
  • Maintain detailed electronic lab records and communicate findings clearly
  • Design, script, and maintain automated workflows (ELISA, qPCR, JESS Western Blot, etc.), including troubleshooting and instrument maintenance
  • Train and support scientists on automation platforms

Skills

Tecan Fluent
laboratory automation
ELISA
qPCR
JESS Western Blot
automation scripting
high-throughput assays
statistical analysis
biomarker development
sample processing
instrument maintenance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI